Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02392754Not ApplicableCompleted

Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older

Role: collaborator

NCT01002989Completed

Validation of WatchBP Office Ankle-brachial Index (ABI) Function

Role: collaborator

NCT00861354Completed

Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor

Role: lead

NCT00624598Not ApplicableCompleted

The Short-Term Effect of a Technology Driven Weight Control (SMART) Program for Obese Adults

Role: collaborator

NCT00502931Completed

A Systematic Review on the Accuracy and Reliability the BodyGem/MedGem Metabolic Devices

Role: lead

NCT00489502Unknown

Clinical Observation of Implementing the MedGem Into a Medical Specialty Practice

Role: lead

All 6 trials loaded